These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14709940)

  • 1. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
    DeVane CL; Donovan JL; Liston HL; Markowitz JS; Cheng KT; Risch SC; Willard L
    J Clin Psychopharmacol; 2004 Feb; 24(1):4-10. PubMed ID: 14709940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
    Alfaro CL; Lam YW; Simpson J; Ereshefsky L
    J Clin Pharmacol; 2000 Jan; 40(1):58-66. PubMed ID: 10631623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
    Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mibefradil on CYP3A4 in vivo.
    Veronese ML; Gillen LP; Dorval EP; Hauck WW; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2003 Oct; 43(10):1091-100. PubMed ID: 14517191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    Preskorn SH
    J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Lam YW; Alfaro CL; Ereshefsky L; Miller M
    J Clin Pharmacol; 2003 Nov; 43(11):1274-82. PubMed ID: 14551182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
    Jurima-Romet M; Wright M; Neigh S
    Br J Clin Pharmacol; 1998 Mar; 45(3):318-21. PubMed ID: 10896409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting.
    Lloret-Linares C; Bosilkovska M; Daali Y; Gex-Fabry M; Heron K; Bancila V; Michalopoulos G; Perroud N; Richard-Lepouriel H; Aubry JM; Desmeules J; Besson M
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
    von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI
    Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
    Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.
    Ohno Y; Hisaka A; Suzuki H
    Clin Pharmacokinet; 2007; 46(8):681-96. PubMed ID: 17655375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers.
    Donovan JL; Chavin KD; Devane CL; Taylor RM; Wang JS; Ruan Y; Markowitz JS
    Drug Metab Dispos; 2004 Sep; 32(9):906-8. PubMed ID: 15319329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
    Daniel WA; Haduch A; Syrek M; Boksa J
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect.
    Kotlyar M; Brewer ER; Golding M; Carson SW
    J Clin Psychopharmacol; 2003 Dec; 23(6):652-6. PubMed ID: 14624194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin.
    Paine MF; Wagner DA; Hoffmaster KA; Watkins PB
    Clin Pharmacol Ther; 2002 Nov; 72(5):524-35. PubMed ID: 12426516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
    Haduch A; Wójcikowski J; Daniel WA
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
    Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions of antidepressants.
    Richelson E
    J Clin Psychiatry; 1998; 59 Suppl 10():22-6. PubMed ID: 9720479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.
    Lindh JD; Annas A; Meurling L; Dahl ML; AL-Shurbaji A
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):401-6. PubMed ID: 12898080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.